QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

HOME  |   SEARCH  |   ARCHIVE  |   SUBSCRIBE  |   CONTACT  |   HELP

The Journal of Neuroscience, October 20, 2004, 24(42):9434-9440; doi:10.1523/JNEUROSCI.3080-04.2004

This Article Full Text Full Text (PDF) Submit an eLetter Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in Web of Science Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Web of Science (54) Citing Articles via Google Scholar Google Scholar Articles by Fleming, S. M. Articles by Chesselet, M.-F. Search for Related Content PubMed PubMed Citation Articles by Fleming, S. M. Articles by Chesselet, M.-F.

 Previous Article  |  Next Article 

Neurobiology of Disease
Early and Progressive Sensorimotor Anomalies in Mice Overexpressing Wild-Type Human -Synuclein

Sheila M. Fleming,¹ Jonathan Salcedo,¹ Pierre-Olivier Fernagut,¹ Edward Rockenstein,³ Eliezer Masliah,³ Michael S. Levine,² and Marie-Françoise Chesselet¹

¹Departments of Neurology and Neurobiology, ²The Mental Retardation Research Center, The David Geffen School of Medicine at University of California Los Angeles, Los Angeles, California 90095-1769, and ³Department of Neuroscience, University of California San Diego, La Jolla, California 92093-0624

Accumulation of -synuclein in brain is a hallmark of synucleinopathies, neurodegenerative diseases that include Parkinson's disease. Mice overexpressing -synuclein under the Thy-1 promoter (ASO) show abnormal accumulation of -synuclein in cortical and subcortical regions of the brain, including the substantia nigra. We examined the motor deficits in ASO mice with a battery of sensorimotor tests that are sensitive to alterations in the nigrostriatal dopaminergic system. Male wild-type and ASO mice were tested every 2 months for 8 months for motor performance and coordination on a challenging beam, inverted grid, and pole, sensorimotor deficits in an adhesive removal test, spontaneous activity in a cylinder, and gait. Fine motor skills were assessed by the ability to grasp cotton from a bin. ASO mice displayed significant impairments in motor performance and coordination and a reduction in spontaneous activity as early as 2 months of age. Motor performance and coordination impairments became progressively worse with age and sensorimotor deficits appeared at 6 months. Fine motor skills were altered at 4 months and worsened at 8 months. These data indicate that overexpression of -synuclein induced an early and progressive behavioral phenotype that can be detected in multiple tests of sensorimotor function. These behavioral deficits provide a useful way to assess novel drug therapy in genetic models of synucleinopathies.

Key words: basal ganglia; behavior; movement; Parkinson; nigrostriatal; phenotype

---

Received July 28, 2004; revised September 2, 2004; accepted September 3, 2004.

This article has been cited by other articles:

				N. Ninkina, O. Peters, S. Millership, H. Salem, H. van der Putten, and V. L. Buchman {gamma}-Synucleinopathy: neurodegeneration associated with overexpression of the mouse protein Hum. Mol. Genet., May 15, 2009; 18(10): 1779 - 1794. [Abstract] [Full Text] [PDF]

				X.-H. Lu, S. M. Fleming, B. Meurers, L. C. Ackerson, F. Mortazavi, V. Lo, D. Hernandez, D. Sulzer, G. R. Jackson, N. T. Maidment, et al. Bacterial Artificial Chromosome Transgenic Mice Expressing a Truncated Mutant Parkin Exhibit Age-Dependent Hypokinetic Motor Deficits, Dopaminergic Neuron Degeneration, and Accumulation of Proteinase K-Resistant {alpha}-Synuclein J. Neurosci., February 18, 2009; 29(7): 1962 - 1976. [Abstract] [Full Text] [PDF]

				A. P. Chou, N. Maidment, R. Klintenberg, J. E. Casida, S. Li, A. G. Fitzmaurice, P.-O. Fernagut, F. Mortazavi, M.-F. Chesselet, and J. M. Bronstein Ziram Causes Dopaminergic Cell Damage by Inhibiting E1 Ligase of the Proteasome J. Biol. Chem., December 12, 2008; 283(50): 34696 - 34703. [Abstract] [Full Text] [PDF]

				W. Zhou, J. B. Milder, and C. R. Freed Transgenic Mice Overexpressing Tyrosine-to-Cysteine Mutant Human {alpha}-Synuclein: A PROGRESSIVE NEURODEGENERATIVE MODEL OF DIFFUSE LEWY BODY DISEASE J. Biol. Chem., April 11, 2008; 283(15): 9863 - 9870. [Abstract] [Full Text] [PDF]

				K. S. Rommelfanger, G. L. Edwards, K. G. Freeman, L. C. Liles, G. W. Miller, and D. Weinshenker Norepinephrine loss produces more profound motor deficits than MPTP treatment in mice PNAS, August 21, 2007; 104(34): 13804 - 13809. [Abstract] [Full Text] [PDF]

				S. Jain, J. P. Golden, D. Wozniak, E. Pehek, E. M. Johnson Jr, and J. Milbrandt RET Is Dispensable for Maintenance of Midbrain Dopaminergic Neurons in Adult Mice J. Neurosci., October 25, 2006; 26(43): 11230 - 11238. [Abstract] [Full Text] [PDF]

				C. W. Shults, E. Rockenstein, L. Crews, A. Adame, M. Mante, G. Larrea, M. Hashimoto, D. Song, T. Iwatsubo, K. Tsuboi, et al. Neurological and Neurodegenerative Alterations in a Transgenic Mouse Model Expressing Human {alpha}-Synuclein under Oligodendrocyte Promoter: Implications for Multiple System Atrophy J. Neurosci., November 16, 2005; 25(46): 10689 - 10699. [Abstract] [Full Text] [PDF]

				L. Chen, B. Cagniard, T. Mathews, S. Jones, H. C. Koh, Y. Ding, P. M. Carvey, Z. Ling, U. J. Kang, and X. Zhuang Age-dependent Motor Deficits and Dopaminergic Dysfunction in DJ-1 Null Mice J. Biol. Chem., June 3, 2005; 280(22): 21418 - 21426. [Abstract] [Full Text] [PDF]

				D.-Y. Hwang, S. M. Fleming, P. Ardayfio, T. Moran-Gates, H. Kim, F. I. Tarazi, M.-F. Chesselet, and K.-S. Kim 3,4-Dihydroxyphenylalanine Reverses the Motor Deficits in Pitx3-Deficient Aphakia Mice: Behavioral Characterization of a Novel Genetic Model of Parkinson's Disease J. Neurosci., February 23, 2005; 25(8): 2132 - 2137. [Abstract] [Full Text] [PDF]

Home  |   Search  |   Archive  |   Subscribe  |   Contact  |   Help